Anthera Pharmaceuticals Cash from Financing (TTM) Trends

Anthera Pharmaceuticals Inc (ANTH)

0.00 USD | OTCM | Apr 25, 16:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2009. Upgrade now.

Date	Value
March 31, 2018	19.03M
December 31, 2017	18.25M
September 30, 2017	16.19M
June 30, 2017	34.08M
March 31, 2017	36.08M
December 31, 2016	23.58M
September 30, 2016	23.90M
June 30, 2016	33.89M
March 31, 2016	31.30M
December 31, 2015	75.30M
September 30, 2015	67.61M
June 30, 2015	37.91M
March 31, 2015	37.92M
December 31, 2014	-7.706M
September 30, 2014	-1.076M
June 30, 2014	-0.346M
March 31, 2014	2.835M

Date	Value
December 31, 2013	43.12M
September 30, 2013	41.28M
June 30, 2013	74.61M
March 31, 2013	71.41M
December 31, 2012	31.26M
September 30, 2012	33.59M
June 30, 2012	-0.28M
March 31, 2012	53.81M
December 31, 2011	78.43M
September 30, 2011	78.16M
June 30, 2011	107.94M
March 31, 2011	55.91M
December 31, 2010	87.53M
September 30, 2010	90.75M
June 30, 2010	71.48M
March 31, 2010	69.41M
December 31, 2009	13.04M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Maximum

Average

Median

Cash from Financing (TTM) Benchmarks